Manoj Kumar Sahu
Research Subjects
Manoj Kumar Sahu has a total of 278 co-authors. Here are the top co-authors by number of shared publications:
- Girish Kumar Pati
Professor, Department of Gastroenterology, Institute of Medical Sciences and Sum Hospital, Bhubaneswar, India
7 shared publications - Kanishka Uthansingh
Multi-Speciality Research Unit, KIMS Cancer Center, KIMS Hospital, KIIT University
7 shared publications Jimmy Narayan
Department of Gastroenterology and Hepatobiliary Sciences, IMS and SUM Hospital, Siksha 'O' Anusandhan University, Bhubaneswar, Odisha, India
6 shared publications- Ajit Sood
Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India
5 shared publications - Akash Shukla
Department of Hepatology, Sir HN Reliance Foundation Hospital, Mumbai, Maharashtra, India
5 shared publications - Anand V. Kulkarni
Department of Hepatology, AIG Hospitals, Hyderabad, India
5 shared publications
Latest Publications
- Open Access
ISG Task Force on Upper Gastrointestinal Bleeding (UGIB)—Comparison of Risk Scores in Nonvariceal Bleeding—A Prospective Multicenter Study
Background: To compare the performance of the Glasgow Blatchford score (GBS) to the Total Rockall score (TRS) in predicting clinical interventions in Indian patients with acute nonvariceal upper gastrointestinal bleeding (ANVUGIB). Materials and Methods: We prospectively studied ANVUGIB in 93 hospitals in India from October 2014 to September 2018. The etiological, clinical, and investigational details were recorded on a uniform structured proforma. The GBS and TRS were prospectively calculated for all patients. Clinical interventions were defined as blood transfusion, rebleed, and mortality with 30‐day follow‐up. Results: A total of 6450 patients with ANVUGIB were identified, followed up for 30 days and selected for analysis. Almost 5176 (80%) of the patients were male, and the mean age 50.7 ± 16.8 years (2–98 years). Blood transfusion was considered clinically necessary in 115 (1.7%) of the patients. Surgery and interventional radiology were required as rescue therapy in only 20 patients (0.3%) and 22 (0.3%) patients, respectively. The 30‐day rebleeding and mortality occurred in 92 (1.4%) and in 184 (2.8%) patients, respectively. GBS was similar to TRS in predicting mortality (AUC 0.687 vs. 0.663) with cutoff values of 10.5 and 3.5 and predicting rebleeding with (AUC 0.637 vs. 0.630) cutoff values of 11.5 and 3.5, respectively. Outcomes were defined as 30‐day mortality and rebleeding. Interventions were defined as transfusions, repeat endoscopy, surgery, or interventional radiology. Conclusions: GBS was more accurate and had more desirable clinical characteristics in predicting the need for a transfusion for hospitalized patients than TRS. However, both GBS and TRS have poor to modest predictive capability for 30‐day mortality and rebleeding. They do not, then, appear to be useful as screening tools to identify people at risk for those two outcomes in a hospital setting.
Open AccessISG Task Force on Upper Gastrointestinal Bleeding (UGIB)—Comparison of Risk Scores in Nonvariceal Bleeding—A Prospective Multicenter Study
Background: To compare the performance of the Glasgow Blatchford score (GBS) to the Total Rockall score (TRS) in predicting clinical interventions in Indian patients with acute nonvariceal upper gastrointestinal bleeding (ANVUGIB). Materials and Methods: We prospectively studied ANVUGIB in 93 hospitals in India from October 2014 to September 2018. The etiological, clinical, and investigational details were recorded on a uniform structured proforma. The GBS and TRS were prospectively calculated for all patients. Clinical interventions were defined as blood transfusion, rebleed, and mortality with 30‐day follow‐up. Results: A total of 6450 patients with ANVUGIB were identified, followed up for 30 days and selected for analysis. Almost 5176 (80%) of the patients were male, and the mean age 50.7 ± 16.8 years (2–98 years). Blood transfusion was considered clinically necessary in 115 (1.7%) of the patients. Surgery and interventional radiology were required as rescue therapy in only 20 patients (0.3%) and 22 (0.3%) patients, respectively. The 30‐day rebleeding and mortality occurred in 92 (1.4%) and in 184 (2.8%) patients, respectively. GBS was similar to TRS in predicting mortality (AUC 0.687 vs. 0.663) with cutoff values of 10.5 and 3.5 and predicting rebleeding with (AUC 0.637 vs. 0.630) cutoff values of 11.5 and 3.5, respectively. Outcomes were defined as 30‐day mortality and rebleeding. Interventions were defined as transfusions, repeat endoscopy, surgery, or interventional radiology. Conclusions: GBS was more accurate and had more desirable clinical characteristics in predicting the need for a transfusion for hospitalized patients than TRS. However, both GBS and TRS have poor to modest predictive capability for 30‐day mortality and rebleeding. They do not, then, appear to be useful as screening tools to identify people at risk for those two outcomes in a hospital setting.
- Open Access
- 12 December 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 858
Confirmation of Helicobacter pylori eradication using ¹³C urea breath test: addressing the regional post-treatment outcomes
As a major etiological factor of the gastrointestinal diseases, the presence of Helicobacter pylori (H. pylori) poses a serious concern to the clinical man
- 12 December 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 858
Open AccessConfirmation of Helicobacter pylori eradication using ¹³C urea breath test: addressing the regional post-treatment outcomes
As a major etiological factor of the gastrointestinal diseases, the presence of Helicobacter pylori (H. pylori) poses a serious concern to the clinical man
- 25 October 2025
- Published by Springer Nature in Hepatology International
- Vol. 20 (1) , 149-162
Diabetes mellitus is linked to higher mortality in alcohol-related acute-on-chronic liver failure
Background Acute-on-chronic liver failure (ACLF) is a rapidly progressive syndrome marked by high short-term mortality. While diabetes mellitus (DM) is known to worsen liver-related outcomes, its specific impact on alcohol-related ACLF (ALD-ACLF) remains underexplored. This study aimed to assess the prognostic impact of DM on 90-day outcomes in ALD-ACLF using data from the APASL ACLF Research Consortium (AARC) database. Methods This observational study involved data from 5612 ACLF patients with documented 90-day outcomes. We identified 2096 patients with ALD-ACLF precipitated by alcoholic hepatitis. Patients with non-ALD etiologies, mixed etiologies, or non-alcoholic precipitants were excluded. Diabetic and non-diabetic patients were compared using 1:2 propensity score matching based on key baseline covariates. Survival outcomes were assessed using Kaplan–Meier analysis and multivariable Cox regression. Results After matching, 109 diabetic patients were compared with 218 well-matched non-diabetic controls. Diabetic patients had significantly lower overall survival (32 vs. 57%) and transplant-free survival (31 vs. 50%) compared to non-diabetics (log-rank p < 0.001). On multivariable Cox regression, DM was independently associated with increased 90-day mortality (HR 1.739, 95% CI 1.262–2.395, p < 0.001), along with elevated serum lactate (HR 1.187 per mmol/L, p < 0.001) and creatinine (HR 1.267 per mg/dL, p < 0.001). Conclusion Diabetes mellitus is a significant independent predictor of mortality in patients with ALD-ACLF. These findings highlight the need for early identification and integrated management of diabetes in ACLF care pathways to improve clinical outcomes.
- 25 October 2025
- Published by Springer Nature in Hepatology International
- Vol. 20 (1) , 149-162
Diabetes mellitus is linked to higher mortality in alcohol-related acute-on-chronic liver failure
Background Acute-on-chronic liver failure (ACLF) is a rapidly progressive syndrome marked by high short-term mortality. While diabetes mellitus (DM) is known to worsen liver-related outcomes, its specific impact on alcohol-related ACLF (ALD-ACLF) remains underexplored. This study aimed to assess the prognostic impact of DM on 90-day outcomes in ALD-ACLF using data from the APASL ACLF Research Consortium (AARC) database. Methods This observational study involved data from 5612 ACLF patients with documented 90-day outcomes. We identified 2096 patients with ALD-ACLF precipitated by alcoholic hepatitis. Patients with non-ALD etiologies, mixed etiologies, or non-alcoholic precipitants were excluded. Diabetic and non-diabetic patients were compared using 1:2 propensity score matching based on key baseline covariates. Survival outcomes were assessed using Kaplan–Meier analysis and multivariable Cox regression. Results After matching, 109 diabetic patients were compared with 218 well-matched non-diabetic controls. Diabetic patients had significantly lower overall survival (32 vs. 57%) and transplant-free survival (31 vs. 50%) compared to non-diabetics (log-rank p < 0.001). On multivariable Cox regression, DM was independently associated with increased 90-day mortality (HR 1.739, 95% CI 1.262–2.395, p < 0.001), along with elevated serum lactate (HR 1.187 per mmol/L, p < 0.001) and creatinine (HR 1.267 per mg/dL, p < 0.001). Conclusion Diabetes mellitus is a significant independent predictor of mortality in patients with ALD-ACLF. These findings highlight the need for early identification and integrated management of diabetes in ACLF care pathways to improve clinical outcomes.
- Open Access
- 17 March 2025
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 16 (01) , 002-007
Diagnostic Yield of Endoscopic Ultrasound-Guided Fine Needle Aspiration in Lung Lesions
Background Tissue sampling from lung lesions is done by bronchoscopy, trans-thoracic needle aspiration lung biopsy, endoscopic ultrasound-guided fine needle aspiration (EUS-FNA), endobronchial ultrasound-guided FNA (EBUS-FNA), thoracenteses, or by surgery. Aim The aim of the present study was to evaluate the feasibility and safety of EUS-FNA of lung parenchymal lesions in nondiagnostic bronchoscopy or EBUS-FNA. Methods All consecutive patients who underwent EUS-FNA from solid central lung parenchymal lesions or lung with adrenal lesions after a failed EBUS or bronchoscopic biopsy with available histology were included. The indication for the procedure and clinical outcome measures like adverse events were recorded on uniform structured data forms. Results Of 62 mediastinal EUS-FNA procedures performed during the study, 13 EUS-FNA procedures were performed from central lung lesions with <2 cm from the esophageal wall and prior failed diagnostic bronchoscopy or EBUS-FNA. There were no adverse events in the study. Histologic confirmation was obtained in all the cases. Conclusions EUS-guided FNA of central lung lesions <2 cm from the esophageal wall is technically feasible without any adverse events in failed EBUS-FNA or bronchoscopy cases.
- 17 March 2025
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 16 (01) , 002-007
Open AccessDiagnostic Yield of Endoscopic Ultrasound-Guided Fine Needle Aspiration in Lung Lesions
Background Tissue sampling from lung lesions is done by bronchoscopy, trans-thoracic needle aspiration lung biopsy, endoscopic ultrasound-guided fine needle aspiration (EUS-FNA), endobronchial ultrasound-guided FNA (EBUS-FNA), thoracenteses, or by surgery. Aim The aim of the present study was to evaluate the feasibility and safety of EUS-FNA of lung parenchymal lesions in nondiagnostic bronchoscopy or EBUS-FNA. Methods All consecutive patients who underwent EUS-FNA from solid central lung parenchymal lesions or lung with adrenal lesions after a failed EBUS or bronchoscopic biopsy with available histology were included. The indication for the procedure and clinical outcome measures like adverse events were recorded on uniform structured data forms. Results Of 62 mediastinal EUS-FNA procedures performed during the study, 13 EUS-FNA procedures were performed from central lung lesions with <2 cm from the esophageal wall and prior failed diagnostic bronchoscopy or EBUS-FNA. There were no adverse events in the study. Histologic confirmation was obtained in all the cases. Conclusions EUS-guided FNA of central lung lesions <2 cm from the esophageal wall is technically feasible without any adverse events in failed EBUS-FNA or bronchoscopy cases.
- Open Access
- 17 March 2025
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 16 (01) , 017-023
A Simulation Study to Investigate the Usefulness of a Novel Stricture Model for Training Esophageal Metallic Stent Placement
Background and Aims The training in esophageal self-expanding metallic stent (SEMS) placement for postgraduates needs an efficient and effective simulation model. The aim of the study was to evaluate the usefulness of a novel stricture model for training in esophageal SEMS placement. Methods The study was a pre-test and post-test design without any control group. Three advanced flexible endoscopic courses were conducted from 2022 to 2024. The training sessions involved 20 final-year postgraduate fellows in each session from different centers. The stenting module consisted of a non-tissue esophageal model with deployment of esophageal SEMS. The trainees received a pre-test, followed by an hour of didactic lecture, mentored hands-on sessions on SEMS deployment on the model using stepwise stenting module, and ended by post-test. Assessments included verbal feedbacks and knowledge-based test scores. Results Sixty final-year postgraduate fellows with varying endoscopic experiences participated in the training programs. All the participants had completed more than 100 therapeutic procedures. Three fellows had deployed esophageal SEMS earlier. All the trainees and the instructor had rated the model as excellent or good with stiffer haptics than real tissue. The mean (%) pre-test scores of 17 (29%) improved significantly to 57 (95%) in the mean post-test (%) questionnaire (p < 0.05). There was significant improvement in test questionnaire after the training modules. Conclusion The simulation model using the novel esophageal model for SEMS deployment is effective with good performance evaluation and can be used to train SEMS deployment procedures.
- 17 March 2025
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 16 (01) , 017-023
Open AccessA Simulation Study to Investigate the Usefulness of a Novel Stricture Model for Training Esophageal Metallic Stent Placement
Background and Aims The training in esophageal self-expanding metallic stent (SEMS) placement for postgraduates needs an efficient and effective simulation model. The aim of the study was to evaluate the usefulness of a novel stricture model for training in esophageal SEMS placement. Methods The study was a pre-test and post-test design without any control group. Three advanced flexible endoscopic courses were conducted from 2022 to 2024. The training sessions involved 20 final-year postgraduate fellows in each session from different centers. The stenting module consisted of a non-tissue esophageal model with deployment of esophageal SEMS. The trainees received a pre-test, followed by an hour of didactic lecture, mentored hands-on sessions on SEMS deployment on the model using stepwise stenting module, and ended by post-test. Assessments included verbal feedbacks and knowledge-based test scores. Results Sixty final-year postgraduate fellows with varying endoscopic experiences participated in the training programs. All the participants had completed more than 100 therapeutic procedures. Three fellows had deployed esophageal SEMS earlier. All the trainees and the instructor had rated the model as excellent or good with stiffer haptics than real tissue. The mean (%) pre-test scores of 17 (29%) improved significantly to 57 (95%) in the mean post-test (%) questionnaire (p < 0.05). There was significant improvement in test questionnaire after the training modules. Conclusion The simulation model using the novel esophageal model for SEMS deployment is effective with good performance evaluation and can be used to train SEMS deployment procedures.
- 31 May 2024
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 14 (6) , 101453
Barriers to Live Donor Liver Transplantation (LDLT) in a Tertiary Care Center in Eastern India
- 31 May 2024
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 14 (6) , 101453
Barriers to Live Donor Liver Transplantation (LDLT) in a Tertiary Care Center in Eastern India
- Open Access
- 26 January 2024
- Published by MDPI AG in Gastroenterology Insights
- Vol. 15 (1) , 98-106
Platelet Count/Spleen Diameter Ratio as a Non-Invasive Predictor of Esophageal Varices in Cirrhotic Patients: A Single-Center Experience
(1) Background: The current study examined the correlations between platelet count (PC), spleen diameter (SD), and their ratio to establish a non-invasive technique for predicting the presence of oesophageal varices in cirrhotic patients. (2) Methods: The current study was an observational study conducted in the Gastroenterology Department at IMS and SUM Hospital from November 2019 to November 2021. Consecutive cirrhotic patients without a history of gastrointestinal bleeding were enrolled in the study, and the esophageal varices were assessed. The patients underwent the necessary tests, including upper gastrointestinal endoscopy, liver function testing, abdominal ultrasonography, and full hemograms. All these parameters were analyzed statistically through SPSS version 23, and p ≤ 0.05 was considered statistically significant. (3) Results: There were significant differences between cases with and without esophageal varices in the following parameters: PC, SD and their ratio, hemoglobin, and ALT level. The PC/SD ratio of ≤ 1400 was associated with a sensitivity of 90.9%, specificity of 80.8%, and a positive predictive value of 82.56% in predicting the presence of oesophageal varices, as per receiver operating curve (ROC) analysis in our study. (4) Conclusions: Esophageal varices can be predicted non-invasively using the platelet count, spleen diameter, and PC/SD ratio.
- 26 January 2024
- Published by MDPI AG in Gastroenterology Insights
- Vol. 15 (1) , 98-106
Open AccessPlatelet Count/Spleen Diameter Ratio as a Non-Invasive Predictor of Esophageal Varices in Cirrhotic Patients: A Single-Center Experience
(1) Background: The current study examined the correlations between platelet count (PC), spleen diameter (SD), and their ratio to establish a non-invasive technique for predicting the presence of oesophageal varices in cirrhotic patients. (2) Methods: The current study was an observational study conducted in the Gastroenterology Department at IMS and SUM Hospital from November 2019 to November 2021. Consecutive cirrhotic patients without a history of gastrointestinal bleeding were enrolled in the study, and the esophageal varices were assessed. The patients underwent the necessary tests, including upper gastrointestinal endoscopy, liver function testing, abdominal ultrasonography, and full hemograms. All these parameters were analyzed statistically through SPSS version 23, and p ≤ 0.05 was considered statistically significant. (3) Results: There were significant differences between cases with and without esophageal varices in the following parameters: PC, SD and their ratio, hemoglobin, and ALT level. The PC/SD ratio of ≤ 1400 was associated with a sensitivity of 90.9%, specificity of 80.8%, and a positive predictive value of 82.56% in predicting the presence of oesophageal varices, as per receiver operating curve (ROC) analysis in our study. (4) Conclusions: Esophageal varices can be predicted non-invasively using the platelet count, spleen diameter, and PC/SD ratio.
- Open Access
- 24 April 2023
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 14 (02) , 074-087
Society of Gastrointestinal Endoscopy of India Consensus Guidelines on Endoscopic Ultrasound-Guided Biliary Drainage: Part II (Technical Aspects)
Endoscopic management of bile duct obstruction is a key aspect in gastroenterology practice and has evolved since the first description of biliary cannulation by McCune et al in 1968. Over many decades, the techniques and accessories have been refined, and currently, the first-line management for extrahepatic biliary obstruction is endoscopic retrograde cholangiopancreatography (ERCP). However, even in expert hands, the success rate of ERCP reaches up to 95%. In almost 4 to 16% cases, failure to cannulate the bile duct may necessitate other alternatives such as surgical bypass or, more commonly, percutaneous transhepatic biliary drainage (PTBD). While surgery is associated with high morbidity and mortality, PTBD has a very high reintervention and complication rate (∼80%) and poor quality of life. Almost parallelly, endoscopic ultrasound (EUS) has come a long way from a mere diagnostic tool to a substantial therapeutic option in various pancreaticobiliary diseases. Biliary drainage using EUS-guidance (EUS-BD) has gained momentum since the first report published by Giovannini et al in 2001. The concept of accessing the bile duct through a different route than the papilla, circumventing the shortcomings of PTBD, and sometimes bypassing the actual obstruction have enthused a lot of interest in this novel strategy. The three key methods of EUS-BD entail transluminal, antegrade, and rendezvous approach. Over the past decade, with growing experience, EUS-BD has been found to be equivalent to ERCP or PTBD for malignant obstruction with better success rates. EUS-BD, however, is not devoid of adverse events and can carry fatal adverse events. However, neither the technique of EUS-BD nor the accessories and stents for EUS-BD have been standardized. Additionally, different countries and regions have different availability of the accessories, making generalizability a difficult task. Thus, technical aspects of this evolving therapy need to be outlined. For these reasons, Society of Gastrointestinal Endoscopy of India (SGEI) deemed it appropriate to develop technical consensus statements for performing safe and successful EUS-BD.
- 24 April 2023
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 14 (02) , 074-087
Open AccessSociety of Gastrointestinal Endoscopy of India Consensus Guidelines on Endoscopic Ultrasound-Guided Biliary Drainage: Part II (Technical Aspects)
Endoscopic management of bile duct obstruction is a key aspect in gastroenterology practice and has evolved since the first description of biliary cannulation by McCune et al in 1968. Over many decades, the techniques and accessories have been refined, and currently, the first-line management for extrahepatic biliary obstruction is endoscopic retrograde cholangiopancreatography (ERCP). However, even in expert hands, the success rate of ERCP reaches up to 95%. In almost 4 to 16% cases, failure to cannulate the bile duct may necessitate other alternatives such as surgical bypass or, more commonly, percutaneous transhepatic biliary drainage (PTBD). While surgery is associated with high morbidity and mortality, PTBD has a very high reintervention and complication rate (∼80%) and poor quality of life. Almost parallelly, endoscopic ultrasound (EUS) has come a long way from a mere diagnostic tool to a substantial therapeutic option in various pancreaticobiliary diseases. Biliary drainage using EUS-guidance (EUS-BD) has gained momentum since the first report published by Giovannini et al in 2001. The concept of accessing the bile duct through a different route than the papilla, circumventing the shortcomings of PTBD, and sometimes bypassing the actual obstruction have enthused a lot of interest in this novel strategy. The three key methods of EUS-BD entail transluminal, antegrade, and rendezvous approach. Over the past decade, with growing experience, EUS-BD has been found to be equivalent to ERCP or PTBD for malignant obstruction with better success rates. EUS-BD, however, is not devoid of adverse events and can carry fatal adverse events. However, neither the technique of EUS-BD nor the accessories and stents for EUS-BD have been standardized. Additionally, different countries and regions have different availability of the accessories, making generalizability a difficult task. Thus, technical aspects of this evolving therapy need to be outlined. For these reasons, Society of Gastrointestinal Endoscopy of India (SGEI) deemed it appropriate to develop technical consensus statements for performing safe and successful EUS-BD.
- Open Access
- 16 April 2023
- Published by Qeios Ltd
Review of: "Serological detection strategy and prevalence of HIV and Viral Hepatitis B and C in blood donors in Yaoundé Cameroon"
* Blood donors were screened initially for HBV (Murex HBsAg Version 3), again all samples were retested by Murex HBsAg Version 3, why? * HBsAg positive samples were screened for anti-HBc, IGM anti HBc or total core antibody? * Reactive samples on...
- 16 April 2023
- Published by Qeios Ltd
Open AccessReview of: "Serological detection strategy and prevalence of HIV and Viral Hepatitis B and C in blood donors in Yaoundé Cameroon"
* Blood donors were screened initially for HBV (Murex HBsAg Version 3), again all samples were retested by Murex HBsAg Version 3, why? * HBsAg positive samples were screened for anti-HBc, IGM anti HBc or total core antibody? * Reactive samples on...